Edition:
United States

Edwards Lifesciences Corp (EW)

EW on New York Consolidated

110.64USD
22 Sep 2017
Change (% chg)

-- (--)
Prev Close
$110.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,224,123
52-wk High
$121.75
52-wk Low
$81.12

Summary

Name Age Since Current Position

Michael Mussallem

64 2000 Chairman of the Board, Chief Executive Officer

Scott Ullem

50 2014 Chief Financial Officer, Corporate Vice President

Donald Bobo

55 2007 Corporate Vice President - Heart Valve Therapy

Catherine Szyman

50 2015 Corporate Vice President- Critical Care

Patrick Verguet

59 2004 Corporate Vice President- Europe, Middle East and Africa

Huimin Wang

60 2010 Corporate Vice President- Japan, Asia and Pacific

Larry Wood

51 2007 Corporate Vice President - Transcatheter Heart Valve Therapy

Bernard Zovighian

49 2016 Corporate Vice President -Surgical Heart Valve Therapy

Kieran Gallahue

53 2015 Independent Director

Leslie Heisz

56 2016 Independent Director

William Link

71 2009 Independent Director

Steven Loranger

65 2016 Independent Director

Martha Marsh

68 2016 Independent Director

Nicholas Valeriani

60 2014 Independent Director

Wesley von Schack

72 2012 Presiding Independent Director

David Erickson

Vice President - Investor Relations

Biographies

Name Description

Michael Mussallem

Mr. Michael A. Mussallem is Chairman of the Board, Chief Executive Officer of the Company. He has an extensive knowledge of the medical technology industry in general, and of the people, operations, processes and products of the Company, in particular, built over a 35-year career with the Company and its predecessor. In addition, in his roles with AdvaMed and other healthcare-related organizations, he has become a recognized leader in the medical technology industry, making important contributions to healthcare policy discussions in California, the United States and the key global markets that the Company serves. These experiences have established relationships which are helpful in developing the Board's strategic perspective and enhanced his leadership of the Company and contributions to the Board. He received his Bachelor of Science in Chemical Engineering and an honorary doctoral degree from the Rose Hulman Institute of Technology

Scott Ullem

Mr. Scott B. Ullem has been appointed as Chief Financial Officer, Corporate Vice President of the Edwards Lifesciences Corportion effective January 2, 2014. Prior to joining Edwards, he served from May 2010 to December 2013 as Chief Financial Officer of Bemis Company Inc., a publicly traded global supplier of packaging and pressure sensitive materials used in leading food, consumer and healthcare products. Mr. Ullem also had leadership responsibility for one of Bemis' three business segments and the company's information technology function. Before joining Bemis, Mr. Ullem spent 17 years in investment banking, serving as Managing Director at Goldman Sachs and later for Bank of America. He serves on the Board of Directors of Berry Plastics Group, Inc. and is a Henry Crown Fellow at the Aspen Institute. Mr. Ullem earned a bachelor's degree in political science from DePauw University and an MBA from Harvard Business School.

Donald Bobo

Mr. Donald E. Bobo, Jr., is Corporate Vice President - Heart Valve Therapy of Edwards Lifesciences Corp. He is currently responsible for Edwards' corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the transcatheter mitral and tricuspid therapies organization and heart failure initiatives, as well as the healthcare solutions and commercial services team. Mr. Bobo has more than 30 years of experience in the medical products and healthcare industry including various operating roles at Edwards such as vice president and general manager of the global heart valve therapy business and global valve manufacturing operations. Prior to joining Edwards in 1995, Mr. Bobo held a variety of roles with increasing levels of responsibility with American Hospital Supply and Baxter Healthcare Corporation, including research and development, business development, operations and general management. Currently, Mr. Bobo serves on the board of Innerspace Neuro Solutions Inc. and as Vice Chair of the board of the California Life Sciences Association. He received a bachelor's degree in mathematics from Bob Jones University, and a master's degree in engineering from the University of Southern California.

Catherine Szyman

Ms. Catherine M. Szyman has been Corporate Vice President, Critical Care of Edwards Lifesciences Corporation since January 2015. Prior to 2015, she was employed for more than 20 years at Medtronic, Inc., where she served as its Senior Vice President and President of Medtronic's global diabetes business from 2009 to 2014, overseeing research, development, operations, sales and marketing for Medtronic's insulin infusion pumps and continuous glucose monitoring systems. Prior to that, she held a variety of leadership roles at Medtronic, including Senior Vice President of Global Channel Management and Corporate Strategy and Business Development, Vice President and General Manager of Endovascular Innovations and Vice President of Finance for the Vascular Business. Ms. Szyman previously served on the boards of Tornier, Inspire Medical Systems, and the California Healthcare Institute. She graduated from the University of St. Thomas, and earned her MBA from Harvard Business School.

Patrick Verguet

Mr. Patrick B. Verguet is Corporate Vice President, Europe, Middle East and Africa of Edwards Lifesciences Corp, respectively. He has more than 30 years of medical device experience beginning with Travenol in France and continuing in various positions with Edwards (or Baxter Healthcare Corporation) including Vice President of Sales, Europe; Global Business Director for hemofiltration; Business Unit/Country Manager for Edwards' operations in Western Europe; General Manager of Edwards' Research Medical operations in Utah; and Vice President and General Manager of the Cardiac Surgery Systems business. Mr. Verguet holds a doctorate in Pharmacy from the University of Besançon.

Huimin Wang

Dr. Huimin Wang M.D., is Corporate Vice President, Japan, Asia Pacific of Edwards Lifesciences Corporation. From 2004 to 2010. Dr. Wang has been Corporate Vice President, Japan, Asia and Pacific since 2010. Previously, he served in a number of roles with Baxter Healthcare Corporation, including Senior Manager of Strategy Development, Director of Product/Therapy for the Renal Division in Japan, President of Medical Systems and Devices in Japan, and was a representative director of Baxter Limited, a Japan corporation, through September 2002. Before joining Baxter, Dr. Wang was a senior associate with Booz, Allen & Hamilton in Chicago, Vice President of Integrated Strategies, a consulting and venture management firm he co-founded, and an associate with McKinsey & Company. Dr. Wang is a Visiting Associate Professor of anesthesiology at Keio University. Dr. Wang earned his Doctor of Medicine degree from Kagoshima University in Japan and was a Resident and Staff Physician in anesthesiology at Keio University Hospital in Tokyo. He earned his MBA from the University of Chicago.

Larry Wood

Mr. Larry L. Wood is Corporate Vice President - Transcatheter Heart Valve Therapy of Edwards Lifesciences Corp. since 2007, and is responsible for all Edwards' key initiatives in transcatheter heart valve replacement around the globe, including research and development, operations, marketing, commercial clinical and regulatory initiatives. Most recently prior to his current role, from March 2004 to February 2007, he served as Vice President and General Manager, Percutaneous Valve Interventions. Mr. Wood has more than 30 years of experience in the medical technology industry at both Edwards and Baxter Healthcare Corporation in positions including manufacturing management, regulatory affairs and strategic and clinical marketing, primarily for the surgical heart valve therapy business. Mr. Wood holds an MBA from Pepperdine University.

Bernard Zovighian

Mr. Bernard J. Zovighian has been Corporate Vice President- Surgical Heart Valve Therapy since January 2016. He joined Edwards in January 2015 as Vice President and General Manager for the surgical heart valve business. Prior to joining Edwards, Mr. Zovighian held a variety of roles with increasing levels of responsibility at Johnson & Johnson for nearly 20 years, including Worldwide President of Advanced Sterilization Products from 2011 to 2014, and President of JJMP, Johnson & Johnson's medical technology business in Canada, from 2006 to 2011. Mr. Zovighian has extensive senior leadership experience in the medical device industry in Europe and North America. He has held roles of increasing responsibility in sales, marketing, business development, general management and commercial introduction and adoption of disruptive technology that has elevated the standard of care. Mr. Zovighian holds a master's degree in biomedical engineering from University of Marseille and an executive MBA from Euromed Management.

Kieran Gallahue

Mr. Kieran T. Gallahue is an Independent Director of the Edwards Lifesciences Corporation. He provides valuable insights and direction to the Board gained through extensive executive management experience at medical technology companies. His leadership roles on other public company boards and committees and prior experience as a public company chief financial officer also permits him to contribute valuable financial and accounting perspectives to the Board and Audit Committee. He holds a bachelor's degree in economics from Rutgers University and an MBA from Harvard Business School.

Leslie Heisz

Ms. Leslie Stone Heisz is an Independent Director of the Company. Her career in the banking industry, in-depth knowledge of capital markets, and previous public company board experience enhances our Board's ability to effectively oversee financial reporting, enterprise and operational risk management, as well as corporate finance, tax and treasury matters. Ms. Heisz is also an experienced governance professional, having received the National Association of Corporate Directors' Directorship 100 award. She holds a bachelor's degree in economics-systems science from the University of California and an MBA from the UCLA School of Management.

William Link

Dr. William J. Link, Ph.D., is an Independent Director of the company. His corporate leadership and long history successfully commercializing products in the medical technology industry provide the Board with a valuable perspective in evaluating the prospects of, and risks associated with, existing business operations. In addition, his extensive experience in identifying new business opportunities and his strong technical and engineering background have proven beneficial in assessing the potential for future innovations. He earned his bachelor's, master's and doctoral degrees in mechanical engineering from Purdue University.

Steven Loranger

Mr. Steven R. Loranger is an Independent Director of the Company. He is a seasoned executive with global manufacturing and operational experience in highly regulated, high-tech industries. His decades of experience leading large, global innovation-focused corporations with intensive data privacy components is particularly valuable to the Board. He holds a bachelor's and master's degree in science from the University of Colorado.

Martha Marsh

Ms. Martha H. Marsh is Director of the Company. Her experience of more than 30 years in an increasingly complex and evolving healthcare system as a president and chief executive officer, combined with years of Board experience that includes corporate governance chairmanships, provide a unique perspective as our board considers the execution of our patient-focused innovation strategy. She received her Bachelor of Arts in History from the University of Rochester, an MBA in accounting and health administration and a master's degree in public health from Columbia University.

Nicholas Valeriani

Mr. Nicholas J. Valeriani is an Independent Director of the Companysince November,2014. His 40 years of medical technology industry experience in a large and complex global company and experience directing strategy informs his contribution to the development of our innovation strategy and assessment of future business opportunities. In addition, his background in human resources enables him to contribute valuable insights to the Compensation and Governance Committee. He received a bachelor's degree in industrial engineering and an MBA from Rutgers University.

Wesley von Schack

Dr. Wesley W. von Schack is the Presiding Independent Director of the Company. His experience of more than 30 years in the highly regulated energy industry as both a chief executive officer and a chief financial officer, combined with many years of Board experience and audit and compensation committee chairmanships, enable him to make significant contributions in assessing and managing risks. In addition, the operational and leadership skills developed over his career have provided valuable insights and support to the Board as its Presiding Director. He received his Bachelor of Economics from Fordham University, an MBA from St. John's University and a Ph.D. from Pace University.

David Erickson

Basic Compensation